Lately, there's been a lot of buzz around a secret loophole executive insiders are using to make millions buying and selling their own stocks. It's so powerful ... so profitable ... that most people immediately assume this is just another example of Trump doing what's best for business executives. But surprisingly, this loophole has been on the books for many years and executives have been using it to make HUNDREDS of millions of dollars. And here's the good news.

VKTX Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 4.70%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $81,779,033.02

Viking Therapeutics Insider Trading History Chart

Viking Therapeutics Share Price & Price History

^$42.35

▲ +0.03 (0.07%)

As of 12/24/2024 06:19 PM ET

Days: 30 | 90 | 365

URGENT: This Altcoin Opportunity Won’t Wait – Act Now

From Crypto Swap Profits | Ad

Crypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight.

>> Register for the Workshop Now

Viking Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
11/8/2024	Lawson Macartney	Director	Sell	2,000	$68.67	$137,340.00	47,965
10/28/2024	Greg Zante	CFO	Sell	131,687	$76.61	$10,088,541.07	149,366
10/25/2024	Sarah Kathryn Rouan	Director	Sell	11,000	$80.89	$889,790.00	9,500
9/20/2024	Brian Lian	CEO	Sell	216,130	$70.83	$15,308,487.90	2,304,927
9/20/2024	J. Matthew Singleton	Director	Sell	10,300	$69.50	$715,850.00	9,500
8/21/2024	Brian Lian	CEO	Sell	1,000	$69.90	$69,900.00	2,354,927
8/21/2024	J. Matthew Singleton	Director	Sell	5,700	$69.72	$397,404.00	9,500
8/19/2024	Brian Lian	CEO	Sell	112,870	$65.80	$7,426,846.00	2,354,927
8/19/2024	J. Matthew Singleton	Director	Sell	16,000	$62.22	$995,520.00	9,500
8/14/2024	J. Matthew Singleton	Director	Sell	20,786	$57.53	$1,195,818.58	9,500
7/30/2024	Brian Lian	CEO	Sell	115,859	$57.58	$6,671,161.22	2,354,927
7/30/2024	Marianna Mancini	COO	Sell	18,026	$57.13	$1,029,825.38	362,149
5/3/2024	Greg Zante	CFO	Sell	66,756	$74.69	$4,986,005.64	174,854
5/1/2024	Marianna Mancini	COO	Sell	281,425	$78.66	$22,136,890.50	348,508
2/8/2024	Brian Lian	CEO	Sell	269,079	$26.87	$7,230,152.73	2,184,882
2/8/2024	Sarah Kathryn Rouan	Director	Sell	25,000	$28.05	$701,250.00
1/30/2024	Brian Lian	CEO	Sell	35,000	$23.95	$838,250.00	2,264,882
1/19/2024	Sarah Kathryn Rouan	Director	Sell	30,000	$23.05	$691,500.00
1/4/2024	Greg Zante	CFO	Sell	15,000	$17.90	$268,500.00	180,730
5/16/2023	Charles A. Rowland, Jr.	Director	Sell	40,000	$25.00	$1,000,000.00	30,000
5/1/2023	Brian Lian	CEO	Sell	45,000	$22.45	$1,010,250.00	2,197,963
4/24/2023	Lawson Macartney	Director	Sell	16,000	$22.00	$352,000.00	47,965
4/19/2023	Brian Lian	CEO	Sell	35,000	$21.45	$750,750.00	2,242,963
4/17/2023	Brian Lian	CEO	Sell	155,000	$20.45	$3,169,750.00	2,277,963
4/17/2023	Greg Zante	CFO	Sell	7,500	$20.00	$150,000.00	149,279
4/17/2023	Lawson Macartney	Director	Sell	20,786	$20.00	$415,720.00	47,965
4/17/2023	Marianna Mancini	COO	Sell	12,500	$20.00	$250,000.00	287,763
4/13/2023	Brian Lian	CEO	Sell	79,336	$18.45	$1,463,749.20	2,307,963
4/11/2023	Greg Zante	CFO	Sell	56,295	$18.00	$1,013,310.00	149,279
4/3/2023	Brian Lian	CEO	Sell	22,000	$17.85	$392,700.00	2,232,963
4/3/2023	Greg Zante	CFO	Sell	30,911	$18.00	$556,398.00	147,778
3/31/2023	Brian Lian	CEO	Sell	67,970	$17.45	$1,186,076.50	2,254,963
3/30/2023	Greg Zante	CFO	Sell	131,029	$17.00	$2,227,493.00	147,778
3/29/2023	Marianna Mancini	COO	Sell	41,242	$16.00	$659,872.00	261,895

Media Humiliated: Demo of Elon’s Tech Proves They’re Wrong

From Brownstone Research | Ad

Elon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is not buying it.

Click here to watch this demo and decide for yourself.

SEC Filings (Institutional Ownership Changes) for Viking Therapeutics (NASDAQ:VKTX)

76.03% of Viking Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Viking Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
12/19/2024	Principal Financial Group Inc.	593,528	$37.58M	0.0%	+29.9%	0.533%
11/27/2024	Franklin Resources Inc.	328,124	$21.59M	0.0%	-3.0%	0.294%
11/25/2024	Tidal Investments LLC	15,190	$0.96M	0.0%	+296.8%	0.014%
11/25/2024	World Investment Advisors LLC	3,794	$0.24M	0.0%	N/A	0.003%
11/25/2024	Sanctuary Advisors LLC	5,416	$0.34M	0.0%	+51.3%	0.005%
11/19/2024	Second Line Capital LLC	38,118	$2.41M	0.7%	+34.1%	0.034%
11/16/2024	Geode Capital Management LLC	1,863,667	$118.02M	0.0%	+0.2%	1.672%
11/15/2024	Vestcor Inc	11,700	$0.74M	0.0%	N/A	0.010%
11/15/2024	M&T Bank Corp	5,593	$0.35M	0.0%	N/A	0.005%
11/15/2024	Public Employees Retirement System of Ohio	45,252	$2.87M	0.0%	+12.9%	0.041%
11/15/2024	MML Investors Services LLC	20,352	$1.29M	0.0%	+193.1%	0.018%
11/15/2024	Pier Capital LLC	89,147	$5.64M	0.8%	+55.7%	0.080%
11/15/2024	Orion Portfolio Solutions LLC	7,772	$0.49M	0.0%	N/A	0.007%
11/15/2024	XTX Topco Ltd	4,122	$0.26M	0.0%	-91.5%	0.004%
11/15/2024	National Bank of Canada FI	3,548	$0.23M	0.0%	+2,265.3%	0.003%
11/15/2024	Sphera Funds Management LTD.	133,066	$8.42M	1.3%	N/A	0.119%
11/15/2024	State Street Corp	4,674,067	$295.92M	0.0%	-8.8%	4.194%
11/15/2024	Stifel Financial Corp	131,348	$8.32M	0.0%	+92.1%	0.118%
11/15/2024	Sassicaia Capital Advisers LLC	10,000	$0.63M	1.8%	-48.7%	0.009%
11/15/2024	Portolan Capital Management LLC	125,762	$7.96M	0.6%	+58.3%	0.113%
11/15/2024	Melqart Asset Management UK Ltd	94,107	$5.96M	0.5%	-18.1%	0.084%
11/15/2024	IHT Wealth Management LLC	13,348	$0.85M	0.0%	N/A	0.012%
11/15/2024	Integrated Wealth Concepts LLC	4,862	$0.31M	0.0%	N/A	0.004%
11/15/2024	Hilltop Holdings Inc.	9,777	$0.62M	0.0%	+45.3%	0.009%
11/15/2024	Cinctive Capital Management LP	65,080	$4.12M	0.2%	+81.4%	0.058%
11/15/2024	Concentric Capital Strategies LP	14,288	$0.91M	0.0%	-67.4%	0.013%
11/15/2024	Bamco Inc. NY	474,644	$30.05M	0.1%	-5.6%	0.426%
11/15/2024	Erste Asset Management GmbH	47,000	$2.90M	0.0%	N/A	0.042%
11/14/2024	Bellevue Group AG	16,179	$1.02M	0.0%	+267.7%	0.015%
11/14/2024	Wasatch Advisors LP	227,720	$14.42M	0.1%	-10.1%	0.204%
11/14/2024	Fred Alger Management LLC	488,869	$30.95M	0.2%	-13.8%	0.439%
11/14/2024	Braidwell LP	1,156,977	$73.25M	2.1%	+4.5%	1.038%
11/14/2024	Eventide Asset Management LLC	452,969	$28.68M	0.5%	+79.1%	0.406%
11/14/2024	Verition Fund Management LLC	7,721	$0.49M	0.0%	+80.6%	0.007%
11/14/2024	Rockefeller Capital Management L.P.	34,023	$2.15M	0.0%	+109.1%	0.031%
11/14/2024	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	472,244	$29.90M	0.0%	-1.5%	0.424%
11/14/2024	Financial Counselors Inc.	45,981	$2.91M	0.0%	N/A	0.041%
11/14/2024	Zurcher Kantonalbank Zurich Cantonalbank	22,823	$1.45M	0.0%	+2.9%	0.020%
11/14/2024	Stone House Investment Management LLC	500	$32K	0.0%	+66.7%	0.000%
11/13/2024	BNP Paribas Financial Markets	86,712	$5.49M	0.0%	-66.2%	0.078%
11/13/2024	D.A. Davidson & CO.	3,844	$0.24M	0.0%	N/A	0.003%
11/13/2024	FMR LLC	16,619,430	$1.05B	0.1%	+0.5%	14.913%
11/13/2024	The Manufacturers Life Insurance Company	24,630	$1.56M	0.0%	+20.3%	0.022%
11/13/2024	Bank of Montreal Can	35,252	$2.17M	0.0%	+548.8%	0.032%
11/13/2024	Mirabella Financial Services LLP	7,839	$0.50M	0.0%	+21.6%	0.007%
11/13/2024	Independent Advisor Alliance	5,050	$0.32M	0.0%	+19.6%	0.005%
11/12/2024	Westfield Capital Management Co. LP	930,370	$58.90M	0.3%	+18.3%	0.835%
11/12/2024	Crewe Advisors LLC	16,366	$1.04M	0.1%	N/A	0.015%
11/12/2024	Algert Global LLC	31,264	$1.98M	0.1%	-6.8%	0.028%
11/12/2024	Cerity Partners LLC	13,969	$0.88M	0.0%	N/A	0.013%
11/12/2024	Citigroup Inc.	129,345	$8.19M	0.0%	+13.7%	0.116%
11/12/2024	Raymond James Trust N.A.	4,410	$0.28M	0.0%	N/A	0.004%
11/12/2024	Charles Schwab Investment Management Inc.	715,597	$45.30M	0.0%	+6.6%	0.642%
11/12/2024	Activest Wealth Management	1,745	$0.11M	0.0%	+40.2%	0.002%
11/12/2024	Massachusetts Financial Services Co. MA	248,269	$15.72M	0.0%	+4.9%	0.223%
11/8/2024	JW Asset Management LLC	45,000	$2.85M	1.3%	N/A	0.040%
11/8/2024	Connor Clark & Lunn Investment Management Ltd.	158,349	$10.03M	0.0%	+218.2%	0.142%
11/8/2024	Avior Wealth Management LLC	3,172	$0.20M	0.0%	+39.1%	0.003%
11/8/2024	Prospera Financial Services Inc	4,707	$0.30M	0.0%	N/A	0.004%
11/7/2024	Meeder Asset Management Inc.	1,958	$0.12M	0.0%	+144.1%	0.002%
11/7/2024	Quest Partners LLC	1,080	$68K	0.0%	-14.1%	0.001%
11/7/2024	Swiss National Bank	193,800	$12.27M	0.0%	+0.1%	0.174%
11/7/2024	Thrivent Financial for Lutherans	28,251	$1.79M	0.0%	+2.7%	0.025%
11/6/2024	LJI Wealth Management LLC	18,400	$1.17M	0.2%	-39.1%	0.017%
11/6/2024	Royce & Associates LP	13,334	$0.84M	0.0%	N/A	0.012%
11/6/2024	OneDigital Investment Advisors LLC	3,260	$0.21M	0.0%	N/A	0.003%
11/6/2024	Curi RMB Capital LLC	6,034	$0.38M	0.0%	N/A	0.005%
11/6/2024	KBC Group NV	2,997	$0.19M	0.0%	+18.7%	0.003%
11/6/2024	Oppenheimer & Co. Inc.	102,324	$6.48M	0.1%	+43.5%	0.092%
11/5/2024	Victory Capital Management Inc.	19,308	$1.22M	0.0%	-33.2%	0.017%
11/5/2024	Aptus Capital Advisors LLC	38,143	$2.42M	0.0%	+34.1%	0.034%
11/5/2024	Prime Capital Investment Advisors LLC	3,719	$0.24M	0.0%	N/A	0.003%
11/5/2024	Verus Capital Partners LLC	3,510	$0.22M	0.0%	N/A	0.003%
11/5/2024	Platform Technology Partners	4,560	$0.29M	0.1%	N/A	0.004%
11/5/2024	GSA Capital Partners LLP	8,160	$0.52M	0.0%	+64.6%	0.007%
11/4/2024	Venturi Wealth Management LLC	3,100	$0.20M	0.0%	N/A	0.003%
11/4/2024	Lisanti Capital Growth LLC	46,865	$2.97M	0.8%	+15.4%	0.042%
11/4/2024	Chartwell Investment Partners LLC	36,666	$2.32M	0.1%	+88.0%	0.033%
11/4/2024	Los Angeles Capital Management LLC	10,948	$0.69M	0.0%	-10.8%	0.010%
11/4/2024	Sigma Planning Corp	15,119	$0.96M	0.0%	N/A	0.014%
11/1/2024	Assetmark Inc.	10,489	$0.66M	0.0%	+712.5%	0.009%
11/1/2024	Cahill Wealth Management LLC	13,780	$0.87M	0.5%	+9.5%	0.012%
11/1/2024	Fiera Capital Corp	291,318	$18.44M	0.1%	N/A	0.261%
11/1/2024	Quantum Private Wealth LLC	84,084	$5.32M	1.8%	+9.3%	0.075%
11/1/2024	Lewis Asset Management LLC	30,395	$1.92M	1.4%	+14.9%	0.028%
10/31/2024	Keudell Morrison Wealth Management	4,306	$0.27M	0.1%	+5.9%	0.004%
10/31/2024	Principal Financial Group Inc.	593,528	$37.58M	0.0%	+29.9%	0.538%
10/30/2024	Cornerstone Capital Inc.	29,770	$1.89M	0.2%	-12.3%	0.027%
10/30/2024	AlphaCentric Advisors LLC	3,500	$0.22M	0.2%	-78.8%	0.003%
10/30/2024	Wetzel Investment Advisors Inc.	3,500	$0.22M	0.1%	+12.9%	0.003%
10/29/2024	Nvwm LLC	15,784	$1M	0.3%	N/A	0.014%
10/29/2024	Emerald Advisers LLC	339,047	$21.47M	0.8%	+3.7%	0.307%
10/29/2024	Van ECK Associates Corp	9,436	$0.57M	0.0%	-42.0%	0.009%
10/29/2024	Harbor Capital Advisors Inc.	139,252	$8.82M	0.4%	+119.5%	0.126%
10/29/2024	Janney Montgomery Scott LLC	20,985	$1.33M	0.0%	-14.7%	0.019%
10/29/2024	Emerald Mutual Fund Advisers Trust	244,526	$15.48M	0.8%	+0.9%	0.222%
10/29/2024	Janney Capital Management LLC	3,457	$0.22M	0.0%	N/A	0.003%
10/29/2024	Private Wealth Partners LLC	6,240	$0.40M	0.0%	+24.8%	0.006%
10/29/2024	F M Investments LLC	47,754	$3.02M	0.1%	+17.0%	0.043%
10/28/2024	Focus Financial Network Inc.	5,154	$0.33M	0.0%	-9.4%	0.005%

Data available starting January 2016

Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trials to treat patients with biopsy-confirmed non-alcoholic steatohepatitis, as well as NAFLD. It also develops VK5211, an orally available non-steroidal selective androgen receptor modulator that is in Phase II clinical trials for the treatment of patients recovering from non-elective hip fracture surgery; VK0612, an orally available Phase IIb-ready drug candidate for type 2 diabetes; VK2735, a novel dual agonist of the glucagon-like peptide, which is in Phase 1 SAD/MAD clinical trial, and VK0214, an orally available tissue and receptor-subtype selective agonist of the TRß for X-linked adrenoleukodystrophy. The company was incorporated in 2012 and is headquartered in San Diego, California.

Today's Range

Now: $42.35

$41.61

$42.91

50 Day Range

MA: $56.65

$38.28

$78.03

52 Week Range

Now: $42.35

$17.23

$99.41

Volume

1,059,667 shs

Average Volume

4,464,014 shs

Market Capitalization

$4.72 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.89

Who are the company insiders with the largest holdings of Viking Therapeutics?: Viking Therapeutics' top insider shareholders include:
Brian Lian (CEO)
Marianna Mancini (COO)
Greg Zante (CFO)
Lawson Macartney (Director)
Charles A Rowland Jr (Director)
J Matthew Singleton (Director)
Sarah Kathryn Rouan (Director)
Learn More about top insider investors at Viking Therapeutics.
Who are the major institutional investors of Viking Therapeutics?: Viking Therapeutics' top institutional investors include:
FMR LLC — 14.91%
State Street Corp — 4.19%
Geode Capital Management LLC — 1.67%
Perpetual Ltd — 1.15%
Braidwell LP — 1.04%
International Assets Investment Management LLC — 0.91%
Learn More about top institutional investors of Viking Therapeutics stock.
Which major investors are selling Viking Therapeutics stock?: In the previous quarter, VKTX stock was sold by these institutional investors:
State Street Corp
BNP Paribas Financial Markets
SG Americas Securities LLC
Fred Alger Management LLC
XTX Topco Ltd
Profit Investment Management LLC
Concentric Capital Strategies LP
Bamco Inc. NY
Within the last year, company insiders that have sold Viking Therapeutics company stock include:
Brian Lian (CEO)
Marianna Mancini (COO)
Greg Zante (CFO)
Lawson Macartney (Director)
Charles A Rowland Jr (Director)
J Matthew Singleton (Director)
Learn More investors selling Viking Therapeutics stock.
Which major investors are buying Viking Therapeutics stock?: Within the previous quarter, VKTX stock was purchased by institutional investors including:
International Assets Investment Management LLC
Perpetual Ltd
Fiera Capital Corp
Eventide Asset Management LLC
Nepsis Inc.
Handelsbanken Fonder AB
Westfield Capital Management Co. LP
Jane Street Group LLC

Has Trump Finally Gone Too Far?

From Insiders Exposed | Ad